{
     "PMID": "15992375",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20050927",
     "LR": "20131121",
     "IS": "0022-3042 (Print) 0022-3042 (Linking)",
     "VI": "94",
     "IP": "4",
     "DP": "2005 Aug",
     "TI": "Prostaglandin H(2)-derived adducts of proteins correlate with Alzheimer's disease severity.",
     "PG": "1140-5",
     "AB": "The formation of cyclooxygenase-derived lipid adducts of protein in brains of patients who had Alzheimer's disease has been investigated. The enzymatic product of the cyclooxygenases, prostaglandin H2, rearranges in part to highly reactive gamma-ketoaldehydes, levuglandin (LG) E(2) and LGD(2). These gamma-ketoaldehydes react with free amines on proteins to yield a covalent adduct. Utilizing analysis of the levuglandinyl-lysine adducts by liquid chromatography-tandem mass spectrometry, we now find that this post-translational modification is increased significantly in the hippocampus in Alzheimer's disease. The magnitude of the increase correlates with the pathological evidence of severity.",
     "FAU": [
          "Zagol-Ikapitte, Irene",
          "Masterson, Tina S",
          "Amarnath, V",
          "Montine, Thomas J",
          "Andreasson, Katrin I",
          "Boutaud, Olivier",
          "Oates, John A"
     ],
     "AU": [
          "Zagol-Ikapitte I",
          "Masterson TS",
          "Amarnath V",
          "Montine TJ",
          "Andreasson KI",
          "Boutaud O",
          "Oates JA"
     ],
     "AD": "Department of Pharmacology, Vanderbilt University, Nashville, TN, USA.",
     "LA": [
          "eng"
     ],
     "GR": [
          "AG05136/AG/NIA NIH HHS/United States",
          "AG15799/AG/NIA NIH HHS/United States",
          "AG24011/AG/NIA NIH HHS/United States",
          "GM15431/GM/NIGMS NIH HHS/United States"
     ],
     "PT": [
          "Journal Article",
          "Research Support, N.I.H., Extramural",
          "Research Support, Non-U.S. Gov't",
          "Research Support, U.S. Gov't, P.H.S."
     ],
     "DEP": "20050630",
     "PL": "England",
     "TA": "J Neurochem",
     "JT": "Journal of neurochemistry",
     "JID": "2985190R",
     "RN": [
          "0 (Lactams)",
          "0 (Nerve Tissue Proteins)",
          "0 (Prostaglandins E)",
          "42935-17-1 (Prostaglandin H2)",
          "91712-41-3 (levuglandin E2)",
          "K3Z4F929H6 (Lysine)"
     ],
     "SB": "IM",
     "MH": [
          "Aged",
          "Aged, 80 and over",
          "Alzheimer Disease/*metabolism/*pathology",
          "Brain/*metabolism/*pathology",
          "Case-Control Studies",
          "Hippocampus/metabolism",
          "Humans",
          "Lactams/metabolism",
          "Lysine/metabolism",
          "Nerve Tissue Proteins/*metabolism",
          "Prostaglandin H2/*metabolism",
          "Prostaglandins E/metabolism",
          "Severity of Illness Index"
     ],
     "EDAT": "2005/07/05 09:00",
     "MHDA": "2005/09/28 09:00",
     "CRDT": [
          "2005/07/05 09:00"
     ],
     "PHST": [
          "2005/07/05 09:00 [pubmed]",
          "2005/09/28 09:00 [medline]",
          "2005/07/05 09:00 [entrez]"
     ],
     "AID": [
          "JNC3264 [pii]",
          "10.1111/j.1471-4159.2005.03264.x [doi]"
     ],
     "PST": "ppublish",
     "SO": "J Neurochem. 2005 Aug;94(4):1140-5. doi: 10.1111/j.1471-4159.2005.03264.x. Epub 2005 Jun 30.",
     "term": "hippocampus"
}